Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

448
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
448
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

500
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
500
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

276
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
276
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

4.0K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

[Biological treatments for rheumatology : specific situations and risks].

Revue medicale suisse·2026
Same author

[Biological treatments for rheumatology : demystifying the risks].

Revue medicale suisse·2025
Same author

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Rheumatology advances in practice·2025
Same author

[Rheumatoid arthritis resistant to our treatments, what to do?]

Revue medicale suisse·2025
Same author

[Rheumatology: what's new in 2024].

Revue medicale suisse·2025
Same author

Long-lasting improvement of refractory antisynthetase syndrome with tocilizumab: a report of two cases.

RMD open·2023

関連する実験動画

Updated: Jan 18, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.0K

リウマチ学:2025年の新しい情報

Marie Dudler1, Thomas Reygaerts1, Jean Dudler1

  • 1Service de rhumatologie, HFR Fribourg - Hôpital cantonal, 1708 Fribourg.

Revue medicale suisse
|January 16, 2026
PubMed
まとめ

新しいリウマチ性関節炎(RA)の層別化基準は、リスクのある個人を特定できます。確立されたRAの新たな治療法には、新しい治療法や迷走神経刺激が含まれ、ペンタキシン3は新しいバイオマーカーとして有望です。

科学分野:

  • リウマチ学
  • 免疫学
  • 医療技術

背景:

  • リウマチ性関節炎(RA)の診断と治療は進化しています。
  • RAのリスク層別化と治療の選択肢には限界があります。
  • 診断マーカーと治療戦略の改善が必要です。

研究 の 目的:

  • リウマチ性関節炎(RA)の検出と管理における最近の進歩をレビューすること。
  • RAの新たな治療標的と非薬理学的介入を強調すること。
  • RAの診断とモニタリングのための新しいバイオマーカーを導入すること。

主な方法:

  • RAの層別化、予防、治療に関する最近の文献のレビュー。
  • 免疫療法や新しいクラスの薬剤を含む新たな治療薬の分析。
  • RAの新しい診断マーカーと非薬理学的治療の評価。

主要な成果:

  • 新しいRA層別化基準は、リスクのある個人の早期検出に役立ちます。
  • 予防的治療は一時的な利益を示しますが、さらなる研究が必要です。
  • 治療困難なRAの新たな治療法には、抗PD-1、GM-CSF阻害剤、二重特異性抗体、迷走神経刺激が含まれます。
キーワード:
リウマチ性関節炎層別化基準ペンタキシン3バイオマーカー治療法

さらに関連する動画

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

822
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.0K

関連する実験動画

Last Updated: Jan 18, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.0K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

822
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.0K
  • ペンタキシン3は、RAの補完的なバイオマーカーとして可能性を示しています。
  • 結論:

    • RAの層別化と早期検出の進歩は非常に重要です。
    • 新たな治療戦略は、確立された難治性RAの選択肢を拡大しています。
    • ペンタキシン3は、既存のRAバイオマーカーパネルに有望な追加となります。